AI Article Synopsis
- Decongestion is a key treatment goal for patients with decompensated heart failure, focusing on reducing excess fluid in the body.
- Current methods for achieving decongestion primarily include diuretics and hemofiltration, though new mechanical technologies are being developed.
- The review covers the underlying causes of decompensated heart failure, the importance of managing cardiac preload, new technologies aimed at preload reduction, and their potential use in clinical settings.
Article Abstract
Decongestion is a cornerstone therapeutic goal for those presenting with decompensated heart failure. Current approaches to clinical decongestion include reducing cardiac preload, which is typically limited to diuretics and hemofiltration. Several new technologies designed to mechanically reduce cardiac preload are in development. In this review, we discuss the pathophysiology of decompensated heart failure; the central role of targeting cardiac preload; emerging mechanical preload reduction technologies; and potential application of these devices.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11426983 | PMC |
| http://dx.doi.org/10.1097/MAT.0000000000002240 | DOI Listing |
Publication Analysis
Top Keywords
heart failure
12
cardiac preload
12
mechanical preload
8
preload reduction
8
decompensated heart
8
reduction harnessing
4
harnessing cornerstone
4
cornerstone heart
4
failure management
4
management improve
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!